FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval - CNBC
- FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval CNBC
- Eli Lilly's donanemab, an Alzheimer's drug, gets FDA endorsement USA TODAY
- Opinion | An Alzheimer's Advance, Not a Cure-All The Wall Street Journal
- FDA panel votes unanimously for Eli Lilly's Alzheimer's treatment Yahoo Finance
- Lilly Alzheimer's Drug Seen Effective by FDA Advisory Panel Bloomberg